Evolent Health Total Assets 2014-2025 | EVH
Evolent Health total assets from 2014 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Evolent Health Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $2,544 |
| 2023 | $2,680 |
| 2022 | $1,817 |
| 2021 | $1,419 |
| 2020 | $1,372 |
| 2019 | $1,498 |
| 2018 | $1,722 |
| 2017 | $1,313 |
| 2016 | $1,200 |
| 2015 | $1,016 |
| 2014 | $37 |
| 2013 | $102 |
| Evolent Health Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $2,653 |
| 2024-12-31 | $2,544 |
| 2024-09-30 | $2,502 |
| 2024-06-30 | $2,475 |
| 2024-03-31 | $2,644 |
| 2023-12-31 | $2,680 |
| 2023-09-30 | $2,670 |
| 2023-06-30 | $2,647 |
| 2023-03-31 | $2,589 |
| 2022-12-31 | $1,817 |
| 2022-09-30 | $1,759 |
| 2022-06-30 | $1,304 |
| 2022-03-31 | $1,339 |
| 2021-12-31 | $1,419 |
| 2021-09-30 | $1,254 |
| 2021-06-30 | $1,293 |
| 2021-03-31 | $1,306 |
| 2020-12-31 | $1,372 |
| 2020-09-30 | $1,392 |
| 2020-06-30 | $1,270 |
| 2020-03-31 | $1,451 |
| 2019-12-31 | $1,498 |
| 2019-09-30 | $1,714 |
| 2019-06-30 | $1,652 |
| 2019-03-31 | $1,629 |
| 2018-12-31 | $1,722 |
| 2018-09-30 | $1,323 |
| 2018-06-30 | $1,322 |
| 2018-03-31 | $1,306 |
| 2017-12-31 | $1,313 |
| 2017-09-30 | $1,299 |
| 2017-06-30 | $1,138 |
| 2017-03-31 | $1,154 |
| 2016-12-31 | $1,200 |
| 2016-09-30 | $851 |
| 2016-06-30 | $853 |
| 2016-03-31 | $856 |
| 2015-12-31 | $1,016 |
| 2015-09-30 | $1,056 |
| 2015-06-30 | $1,040 |
| 2015-03-31 | $76 |
| 2014-12-31 | $37 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $102 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.162B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.883B | 59.65 |
| Hims & Hers Health (HIMS) | United States | $14.668B | 152.40 |
| Doximity (DOCS) | United States | $11.054B | 51.17 |
| Tempus AI (TEM) | United States | $10.008B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.472B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.870B | 60.47 |
| Hinge Health (HNGE) | United States | $3.513B | 0.00 |
| Privia Health (PRVA) | United States | $2.388B | 163.25 |
| 10x Genomics (TXG) | United States | $1.713B | 0.00 |
| Phreesia (PHR) | United States | $1.608B | 0.00 |
| Enovis (ENOV) | United States | $1.544B | 8.61 |
| Azenta (AZTA) | United States | $1.530B | 71.11 |
| Schrodinger (SDGR) | United States | $1.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.476B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 24.55 |
| Claritev (CTEV) | United States | $0.636B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.532B | 0.00 |
| Standard BioTools (LAB) | United States | $0.524B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| TruBridge (TBRG) | United States | $0.315B | 698.67 |
| Outset Medical (OM) | United States | $0.300B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| CapsoVision (CV) | United States | $0.190B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.175B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.077B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |